The global fibrinogen concentrate market size is expected to reach USD 4.19 Billion by 2028 at a CAGR of 6.1%, according to the latest report by Reports and Data. Increasing R&D activities to develop new therapies for bleeding disorders, rising demand for fibrinogen concentrates to treat congenital deficiencies, and high incidence of bleeding disorders across the globe are key factors expected to drive market revenue growth over the forecast period. In addition, increasing number of advanced and innovative in pipeline to treat bleeding disorders is also expected to contribute to revenue growth of the market going ahead.
Fibrinogen concentrate is a lyophilized and purified human
plasma fibrinogen and is widely used as an alternative to traditional sources of
fibrinogen, which is a natural blood protein playing a vital role in
coagulation process. Fibrinogen concentrate has been extensively used and
recommended for bleeding disorders and acquired coagulation disorders in
several countries across the globe as it significantly improves blood clot
firmness and minimizes the need for postoperative transfusion. Fibrinogen
concentrate can either be plasma-derived or a recombinant and is often used for
afibrinogenemia and dysfibrinogenemia. Increasing research is being carried out
across the globe to expand its application scope to use it for conditions such
as hemorrhage resuscitation. This is expected to contribute to revenue growth
of the market going ahead.
New product launches and approvals of fibrinogen concentrates are also expected to be a key factor driving market growth. In addition, increasing focus of key players on developing advanced fibrinogen concentrates to treat bleeding disorders is also a key market growth driving factor. However, adverse reactions associated with fibrinogen concentrate such as arterial thrombosis, dyspnea, nausea, and others are expected to hamper market growth to a certain extent over the forecast period.
Request a sample Report of Fibrinogen Concentrate Market
@ https://www.reportsanddata.com/sample-enquiry-form/58
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviours are shifting in a variety of ways, from growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Read Full Report Description @ https://www.reportsanddata.com/report-detail/fibrinogen-concentrate-market
Key Players covered in this report are
CSL Behring, Baxter, Johnson & Johnson (Ethicon), LFB Group, ProFibrix BV (The Medicines Company), Shanghai RAAS, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, and Greencross.
For the purpose of this report, Reports and Data has segmented the global fibrinogen concentrate market on the basis of type, application type, and region:
Type Outlook (Revenue, USD Billion; Volume in Tons,
2018–2028)
- Human
- Animal
Application Type Outlook (Revenue, USD Billion; Volume in
Tons, 2018–2028)
- Congenital
Fibrinogen Deficiency
- Surgical Procedures
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Request For customization @ https://www.reportsanddata.com/request-customization-form/58
Major Points covered in this report are as below:
• The Fibrinogen Concentrate industry development trends and marketing channels
are analyzed. The feasibility of new investment projects are assessed and
overall research conclusions offered.
• With the tables and figures, the report provides key statistics on the state
of the industry and is a valuable source of guidance and direction for
companies and individuals interested in the market.
• Development policies and plans, manufacturing processes and cost structures
are also analyzed. This report also states import/export consumption, supply
and demand figures, cost, price, revenue and gross margins.
• The Fibrinogen Concentrate Market report provides key statistics on the
market status of the Fibrinogen Concentrate manufacturers and is a valuable
source of guidance and direction for companies and individuals interested in
the industry.
We can also provide the customized data for separate regions like North
America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan,
South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe,
Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South
America, Brazil, Argentina, Rest of South America, Middle East & Africa,
Saudi Arabia, Turkey, Rest of Middle East & Africa
